One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease

Pharmacology

Volumn 85, Issue 2, 2010, Pages 63-67

  Riccioni, Graziano ^a   Vitulano, Nicola ^b   Mancini, Barbara ^c   Zanasi, Alessandra ^d   D'Orazio, Nicolantonio ^c  

^a San Camillo de Lellis Hospital   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Carotid arteries; Cholesterol; Intima media thickness; Rosuvastatin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL; FLUOROBENZENE; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON CAROTID ARTERY; DIET RESTRICTION; DRUG SAFETY; ECHOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MALE; PHYSICAL EXAMINATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VENOUS BLOOD; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECTS; INTIMA; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TUNICA MEDIA;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FLUOROBENZENES; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIMIDINES; SULFONAMIDES; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 75149120670     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276476     Document Type: Article

References (24)

1. Fleming RM: Angina and coronary ischemia are the result of coronary regional blood flow differences. J Am Coll Angiol 2003;1:127-142.
2. Schoen FJ: The Heart in Robbin's Pathological Basis of Disease, ed 5. New York, WB Saunders Co, 1994, pp 517-582.
3. Lusis AJ: Atherosclerosis. Nature 2000;407:233-241.
4. Zureik M, Ducimetiere P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C, Magne C: Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000;20:1622-1629.
5. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 1991;134:250-256.
6. Salonen R, Salonen JT: Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991;229:225-231.
7. Davis PH, Dawson JD, Riley WA, Lauer RM: Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 2001;104:2815-2819.
8. Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-1249.
9. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, ASTEROID Investigators: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006;295:1556-1565.
10. Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, METEOR Study Group: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007;297:1344-1353.
11. Riccioni G, Bazzano LA, Bucciarelli T, Mancini B, Di Ilio E, D'Orazio N: Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study. Expert Opin Pharmacother 2008;9:2403-2408.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
13. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 1991;337:1235-1243.
14. Kanters SD, Algra A, van Leeuwen MS, Banga JD: Reproducibility of in vivo carotid intima-media thickness measurements. Stroke 1997;28:665-671.
15. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL: Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993;24:1297-1304.
16. Crouse JR 3rd, Byngton RP, Bond MG: Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC II). Am J Cardiol 1995;75:455-459.
17. Riccioni G: Statins and carotid intima-media thickness reduction: an up-to-date review. Curr Med Chem 2009;16:1799-1805.
18. Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse JR 3rd, METEOR Study Group: Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. J Intern Med 2009;265:698-707.
19. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN: ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation 2002;106:2055-2060.
20. Salonen R, Nyyssonen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT: Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758-1764.
21. Smilde TJ, van den Berkmortel FW, Wollersheim H, van Langen H, Kastelein JJ, Stalenhoef AF: The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest 2000;30:473-480.
22. Igarashi M, Takeda Y, Mori S, Ishibashi N, Komatsu E, Takahashi K, Saito J: BAYw6228 suppresses accumulation of macrophages in balloon-induced intimal thickening of rabbit carotid artery. Atherosclerosis 1997;128:251-254.
23. Pauletto O, Puato M, Faggin E, Sartore S: Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous Watanabe hyper lipidemic rabbits. J Vasc Res 2000;37:189-194.
24. Davis M, Atwal AS, Nair DR, Jagroop IA, Seifalian AM, Mikhailidis DP, Hamilton G: The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripheral vascular disease: a pilot study. Curr Med Res Opin 2000;16:198-204.